Bionime Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 425.65 million compared to TWD 573.33 million a year ago. Net income was TWD 10.53 million compared to TWD 39.25 million a year ago. Basic earnings per share from continuing operations was TWD 0.17 compared to TWD 0.65 a year ago. Diluted earnings per share from continuing operations was TWD 0.17 compared to TWD 0.64 a year ago.
For the six months, sales was TWD 840.77 million compared to TWD 1,048.98 million a year ago. Net income was TWD 4.88 million compared to TWD 53.04 million a year ago. Basic earnings per share from continuing operations was TWD 0.08 compared to TWD 0.88 a year ago. Diluted earnings per share from continuing operations was TWD 0.08 compared to TWD 0.87 a year ago.